Clearseq1-4 classifier in localized and metastatic clear-cell renal cell carcinoma (ccRCC)

被引：0
|
作者：
Kinget, L. [1 ]
Roussel, E. [2 ]
Verbiest, A. T. L. [1 ]
Lambrechts, D. [3 ,4 ]
Boeckx, B. [3 ,4 ]
Zucman-Rossi, J. [5 ]
Couchy, G. [5 ]
Caruso, S. [5 ]
Baldewijns, M. [6 ]
De Wever, L. [7 ]
Albersen, M. [2 ]
Beuselinck, B. [1 ]
机构：
[1] UZ Leuven Univ Hosp Leuven, Med Oncol Dept, Campus Gasthuisberg, Leuven, Belgium
[2] Univ Hosp Leuven, Urol, Campus Gasthuisberg, Leuven, Belgium
[3] Katholieke Univ Leuven, Dept Human Genet, Lab Translat Genet, Leuven, Belgium
[4] VIB KULeuven Ctr Canc Biol CCB, VIB Ctr Canc Biol, Leuven, Belgium
[5] Sorbonne Univ, Univ Paris, Ctr Rech Cordeliers, INSERM1138, Paris, France
[6] UZ Leuven Univ Hosp Leuven, Pathol, Campus Gasthuisberg, Leuven, Belgium
[7] UZ Leuven Univ Hosp Leuven, Radiol, Campus Gasthuisberg, Leuven, Belgium
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1478P
引用
收藏
页码：S1222 / S1223
页数：2
相关论文
共 50 条
  • [21] Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
    Nayak, Brusabhanu
    Panaiyadiyan, Sridhar
    Singh, Prabhjot
    Karmakar, Subhradip
    Kaushal, Seema
    Seth, Amlesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 135.e9 - 135.e15
  • [22] Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
    Chatwal, Monica Sheila
    Chahoud, Jad
    Spiess, Philippe E.
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 314 - 326
  • [23] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Nerich, Virginie
    Hugues, Marion
    Paillard, Marie Justine
    Borowski, Laetitia
    Nai, Thierry
    Stein, Ulrich
    Hon, Thierry Nguyen Tan
    Montcuquet, Philippe
    Maurina, Tristan
    Mouillet, Guillaume
    Kleinclauss, Francois
    Pivot, Xavier
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    ONCOTARGETS AND THERAPY, 2014, 7 : 365 - 374
  • [24] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Hugues, Marion
    Nerich, V
    Nai, T.
    Paillard, M. J.
    Borowski, L.
    Stein, U.
    Hon, Nguyen Tan T.
    Montcuquet, P.
    Maurina, T.
    Mouillet, G.
    Kleinclauss, F.
    Pivot, X.
    Thiery-Vuillemin, A.
    Limat, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 271 - 271
  • [25] The Immunohistochemical Distinction between Clear-Cell Renal-Cell Carcinoma and Other Forms of Clear-Cell Carcinoma
    Wendroth, S. M.
    Mentrikoski, M. J.
    Wick, M. R.
    LABORATORY INVESTIGATION, 2013, 93 : 257A - 257A
  • [26] The Immunohistochemical Distinction between Clear-Cell Renal-Cell Carcinoma and Other Forms of Clear-Cell Carcinoma
    Wendroth, S. M.
    Mentrikoski, M. J.
    Wick, M. R.
    MODERN PATHOLOGY, 2013, 26 : 257A - 257A
  • [27] Immunotherapy of Clear-Cell Renal-Cell Carcinoma
    Grigolo, Sophie
    Filgueira, Luis
    CANCERS, 2024, 16 (11)
  • [28] Molecular Genetics of Clear-Cell Renal Cell Carcinoma
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1968 - +
  • [29] The epigenetic landscape of clear-cell renal cell carcinoma
    Kluzek, Katarzyna
    Bluyssen, Hans A.
    Wesoly, Joanna
    JOURNAL OF KIDNEY CANCER AND VHL, 2015, 2 (03): : 90 - 104
  • [30] Characterizing sites of metastatic involvement in metastatic clear-cell, papillary, and chromophobe renal cell carcinoma.
    Dudani, Shaan
    de Velasco, Guillermo
    Wells, Connor
    Gan, Chun Loo
    Donskov, Frede
    Porta, Camillo
    Fraccon, Anna
    Pasini, Felice
    Lee, Jae-Lyun
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Pal, Sumanta K.
    Yuasa, Takeshi
    Kroeger, Nils
    Kanesvaran, Ravindran
    Reaume, M. Neil
    Canil, Christina M.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345